{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:04:55Z","timestamp":1788851095486,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ctro.2024.100835","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T18:19:10Z","timestamp":1722449950000},"page":"100835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Acute toxicities in proton therapy for head and neck cancer \u2013 A matched analysis of the DAHANCA 35 feasibility study"],"prefix":"10.1016","volume":"48","author":[{"given":"K.","family":"Nowicka-Matus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Friborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.R.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bernsdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.V.","family":"Elstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sams\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sibolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Smulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctro.2024.100835_b0005","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2007.04.021","article-title":"Impact of Radiation-Induced Xerostomia on Quality of Life After Primary Radiotherapy Among Patients With Head and Neck Cancer","volume":"69","author":"Jellema","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"22","key":"10.1016\/j.ctro.2024.100835_b0010","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1200\/JCO.2007.14.6647","article-title":"Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy","volume":"26","author":"Langendijk","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2024.100835_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2011.12.010","article-title":"Intensity-modulated radiotherapy in head and neck cancer: Results of the prospective study GORTEC 2004\u201303","volume":"103","author":"Toledano","year":"2012","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2024.100835_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2008.07.059","article-title":"Intensity-Modulated Radiotherapy Reduces Radiation-Induced Morbidity and Improves Health-Related Quality of Life: Results of a Nonrandomized Prospective Study Using a Standardized Follow-Up Program","volume":"74","author":"Vergeer","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2024.100835_b0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","article-title":"Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review","volume":"66","author":"Trotti","year":"2003","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2024.100835_b0030","doi-asserted-by":"crossref","DOI":"10.3109\/0284186X.2013.824609","article-title":"Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer","volume":"52","author":"Mortensen","year":"2013","journal-title":"Acta Oncol (madr)"},{"key":"10.1016\/j.ctro.2024.100835_b0035","article-title":"Adverse Events Associated With Concurrent Chemoradiation Therapy in Patients With Head and Neck","volume":"135","author":"Givens","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2024.100835_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2020.03.013","article-title":"Prediction of radiation-induced mucositis of H&N cancer patients based on a large patient cohort","volume":"147","author":"Hansen","year":"2020","journal-title":"Radiother Oncol"},{"issue":"1107","key":"10.1016\/j.ctro.2024.100835_b0045","doi-asserted-by":"crossref","first-page":"20190955","DOI":"10.1259\/bjr.20190955","article-title":"Reduced radiation-induced toxicity by using proton therapy for the treatment of oropharyngeal cancer","volume":"93","author":"Meijer","year":"2020","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.ctro.2024.100835_b0050","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1634\/theoncologist.2010-0171","article-title":"The Potential Benefit of Radiotherapy with Protons in Head and Neck Cancer with Respect to Normal Tissue Sparing: A Systematic Review of Literature","volume":"16","author":"Water","year":"2011","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.ctro.2024.100835_b0055","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijrobp.2004.09.064","article-title":"Proton radiation for treatment of cancer of the oropharynx: Early experience at Loma Linda University Medical Center using a concomitant boost technique","volume":"62","author":"Slater","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2024.100835_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2016.02.021","article-title":"Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma","volume":"95","author":"Gunn","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2024.100835_b0065","article-title":"Proton Therapy for Locally Advanced Oropharyngeal Cancer: Initial Clinical Experience at the University of Washington","volume":"6","author":"Aljabab","year":"2019","journal-title":"Int J Part Ther"},{"issue":"3","key":"10.1016\/j.ctro.2024.100835_b0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152477","article-title":"Robust Intensity Modulated Proton Therapy (IMPT) increases estimated clinical benefit in head and neck cancer patients","volume":"11","author":"Van Dijk","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ctro.2024.100835_b0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.meddos.2016.01.002","article-title":"Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis","volume":"41","author":"Holliday","year":"2016","journal-title":"Med Dosim"},{"issue":"3","key":"10.1016\/j.ctro.2024.100835_b0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijrobp.2018.12.055","article-title":"A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer","volume":"104","author":"Rwigema","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2024.100835_b0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.radonc.2017.05.006","article-title":"Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer","volume":"123","author":"Zhang","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100835_b0090","doi-asserted-by":"crossref","unstructured":"Meijer TH, Langendijk SD, Meijer TWH, Scandurra D, Langendijk JA. Proton TheraPy SPecial Feature: Review Article Reduced Radiation-Induced Toxicity by Using Proton Therapy for the Treatment of Oropharyngeal Cancer.; 2020.","DOI":"10.1259\/bjr.20190955"},{"issue":"1","key":"10.1016\/j.ctro.2024.100835_b0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2012.03.004","article-title":"NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: The role of dosimetric and clinical factors","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2024.100835_b0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2011.08.009","article-title":"Predictive modelling for swallowing dysfunction after primary (chemo)radiation: Results of a prospective observational study","volume":"105","author":"Christianen","year":"2012","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2024.100835_b0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2024.100835_b0110","doi-asserted-by":"crossref","DOI":"10.1080\/0284186X.2019.1654129","article-title":"NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy","volume":"58","author":"Hansen","year":"2019","journal-title":"Acta Oncol (madr)"},{"key":"10.1016\/j.ctro.2024.100835_b0115","article-title":"Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer","volume":"2023","author":"Friborg","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100835_b0120","first-page":"147","article-title":"TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer","volume":"38","author":"Thomson","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2024.100835_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2017.09.019","article-title":"Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy","volume":"126","author":"Hansen","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100835_b0130","first-page":"151","article-title":"The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines","author":"Jensen","year":"2020","journal-title":"Radiother Oncol"},{"issue":"9388","key":"10.1016\/j.ctro.2024.100835_b0135","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ctro.2024.100835_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2006.02.005","article-title":"The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires","volume":"78","author":"Jensen","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100835_b0145","article-title":"Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35","volume":"xxxx):109812","author":"Hansen","year":"2023","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2024.100835_b0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2016.05.022","article-title":"Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer \u2013 A case matched analysis","volume":"120","author":"Blanchard","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100835_b0155","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2020.03.010","article-title":"Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer","volume":"147","author":"Manzar","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100835_b0160","doi-asserted-by":"crossref","unstructured":"Romesser PB, Cahlon O, Scher E, et al. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. In: Radiotherapy and Oncology. Vol 118. Elsevier Ireland Ltd; 2016:286-292. doi:10.1016\/j.radonc.2015.12.008.","DOI":"10.1016\/j.radonc.2015.12.008"},{"issue":"4","key":"10.1016\/j.ctro.2024.100835_b0165","article-title":"Trends and disparities of proton therapy use among patients with head and neck cancer: Analysis from the national cancer database (2005\u201314)","volume":"5","author":"Lee","year":"2020","journal-title":"Int J Part Ther"},{"issue":"November 2023","key":"10.1016\/j.ctro.2024.100835_b0170","article-title":"Exploring patient-reported barriers to participating in proton therapy clinical trials. Tech Innov Patient Support","volume":"29","author":"Wilh\u00f8ft Kristensen","year":"2024","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100835_b0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2021.09.003","article-title":"Can the mean linear energy transfer of organs be directly related to patient toxicities for current head and neck cancer intensity-modulated proton therapy practice?","volume":"165","author":"Wagenaar","year":"2021","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2024.100835_b0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamaoto.2022.4165","article-title":"Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer","volume":"149","author":"Singh","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surgery"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824001125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824001125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T05:11:52Z","timestamp":1728537112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630824001125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":36,"alternative-id":["S2405630824001125"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100835","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute toxicities in proton therapy for head and neck cancer \u2013 A matched analysis of the DAHANCA 35 feasibility study","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100835"}}